跳至主要内容
临床试验/NCT06865716
NCT06865716进行中(未招募)不适用

Effects of Early Non-invasive Vagus Nerve Stimulation on Infarct Damage and Functioning After Acute ST-elevation Myocardial Infarction

Bnai Zion Medical Center1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2023年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
60
试验地点
1
主要终点
Wall Motion Score Index

研究概览

简要总结

The goal of this clinical trial is to investigate whether early non-invasive vagus nerve stimulation (nVNS) can reduce infarct damage and improve functioning after acute ST-elevation myocardial infarction (STEMI). It will assess the safety and effectiveness of nVNS in improving cardiac outcomes. The main questions it aims to answer are:

  • Does nVNS improve short-term prognosis post-STEMI by enhancing heart rate variability (HRV) and reducing inflammation?
  • Does nVNS reduce infarct size, improve left ventricular function, and lower inflammatory markers compared to sham stimulation?

Participants will be randomly assigned to one of two groups:

  • Experimental group: Receive standard care plus nVNS for 60 minutes at the right ear using the Parasym device under ECG monitoring.
  • Control group: Receive standard care plus sham nVNS (placebo-like procedure without stimulation).

Participants will undergo stimulation once for 60 minutes post-percutaneous coronary intervention (PCI), and be monitored for adverse reactions like bradycardia, with immediate cessation if needed.

Key study details:

  • Inclusion criteria: Adults aged 25-75 years with confirmed STEMI (clinical signs and elevated troponin).
  • Exclusion criteria: Bradycardia (HR < 50 bpm), extensive anterior MI, hypotension, or severe cardiac/medical conditions.
  • Intervention parameters: Stimulation targeting the auricular branch of the vagal nerve with 200µs pulse width, 20Hz frequency, and adjustable intensity (10-50mA), remaining below the pain threshold.

Outcomes measured:

  • Primary outcomes: Wall motion score index (WMSI) and left ventricular ejection fraction (LVEF).
  • Secondary outcomes: HRV metrics, troponin levels, inflammatory markers (CRP, NLR), atrial fibrillation events, hospitalization duration, one-month survival, quality of life (HeartQOL scale), and one-year survival.

Statistical analysis: Researchers will compare baseline characteristics using t-tests and chi-square tests. Main analyses will involve repeated measures mixed-design ANOVA and multivariate ANOVA. Moderation analysis will assess the influence of the experimental condition on inflammation and clinical outcomes.

Ethical considerations: The study complies with Israeli Ministry of Health guidelines for emergency clinical trials. Participants will provide verbal consent followed by written consent. Ethical approval was granted by the IRB of Bnai Zion Medical Center, Haifa, Israel (Approval No. 0169-21-BNZ).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

盲法说明

The participants did not know if they were receiving actual stimulation or not. and the ECHO technician who calculated the ECHO results also did not know the arm of the patient

入排标准

年龄范围
25 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Having had an MI verified by clinical signs (e.g., pain in the chest, left arm, left shoulder), ST-elevation MI (STEMI) and clinically significant elevations of troponin values (cut-off value 19 ng/l or using sex-specific cut-off values of 14ng/l for women and 22ng/l for men.
  • •Between 25-75 years of age.
  • •Patients with Intra-Aortic Balloon.

排除标准

  • •Heart rate (HR) < 50 bpm (bradycardia)
  • •Extensive anterior MI: According to infarct size criteria: KILLIP III & KILLIP IV of Heart Failure following MI is defined as Extensive anterior MI.
  • •Hypotension (systolic blood pressure < 90mmHg).
  • •Sildenafil treatment.
  • •Diagnosed with Atrial Fibrillation.
  • •Diagnosed with Ventricular arrythmias not including Accelerated Idio Ventricular Rhythm (AIVR).
  • •Anaesthetize patient.
  • •Mechanical ventilated patient.
  • •Participation in another trial

研究组 & 干预措施

Post PCI STEMI patients treated with early active noninvasive vagus nerve stimulation

Experimental

The patients received 60 minutes of electrical vagus nerve stimulation via electrode attached to the ear.

干预措施: Active noninvasive vagus nerve stimulation (Device)

Post PCI STEMI patients received the clip stimulator on the lower ear lobe without stimulation

Sham Comparator

Post PCI STEMI patients in the control arm received the clip stimulator on the lower ear lobe without stimulation

干预措施: Chum electrode attached to patient's lower ear lobe (Other)

结局指标

主要结局

Wall Motion Score Index

时间窗: One to 2 days after stimulation: 24-48 hours post-stimulation

The wall motion score index (WMSI) numerically sums the average scores for all left ventricular segments into a single parameter. The prognostic value of WMSI has been investigated in small cohorts of patients with acute myocardial infarction, suggesting superiority to LVEF in predicting mortality

Left ventricular ejection fraction (LVEF)

时间窗: One to 2 days after stimulation: 24-48 hours post-stimulation

LVEF is the fraction of chamber volume ejected in systole (stroke volume) in relation to the volume of the blood in the ventricle at the end of diastole (end-diastolic volume). Stroke volume is calculated as the difference between EDV and end-systolic volume (ESV). This activity reviews the calculation of LVEF, its clinical relevance and highlights the role of the interprofessional team in managing patients with depressed LVEF.

次要结局

  • survival(one month after the intervention and one year after)
  • quality of lifeQuality of life will be assessed using the Heart Disease-Specific Quality of Life Questionnaire (HeartQOL).(Data will be collected 24 hours after the intervention and one month after discharge.)
  • inflammatory markers of CRP(Baseline (before intervention), 24 hours post-intervention and 48 hours post-intervention .)
  • inflammatory markers of Neutrophil-to-Lymphocyte Ratio (NLR)(Baseline (before intervention), 24 hours post-intervention and 48 hours post-intervention)
  • Troponin(Baseline (before intervention), 24 hours post-intervention and 48 hours post-intervention)
  • ProBnp(once (within 24 hours of PCI))
  • Time-Domain Indices of HRV(Before the intervention, immediately after the intervention (at 60 minutes), 24 hours post-intervention, and 48 hours post-intervention.)
  • Frequency-Domain Indices of HRV(: Before the intervention, immediately after the intervention (at 60 minutes), 24 hours post-intervention, and 48 hours post-intervention.)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Idit.Dobretzky-Mery

Head of the cardiology and cardiac care unit

Bnai Zion Medical Center

研究点 (1)

Loading locations...

相似试验